HDL in infectious diseases and sepsis
MetadataShow full item record
© The Author(s) 2015. During infection significant alterations in lipid metabolism and lipoprotein composition occur. Triglyceride and VLDL cholesterol levels increase, while reduced HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) levels are observed. More importantly, endotoxemia modulates HDL composition and size: phospholipids are reduced as well as apolipoprotein (apo) A-I, whileserum amyloid A (SAA) and secretory phospholipase A2 (sPLA2) dramatically increase, and, although the total HDL particle number does not change, a significant decrease in the number of small- and medium-size particles is observed. Low HDL-C levels inversely correlate with the severity of septic disease and associate with an exaggerated systemic inflammatory response. HDL, as well as other plasma lipoproteins, can bind and neutralize Gramnegative bacterial lipopolysaccharide (LPS) and Gram-positive bacterial lipoteichoic acid (LTA), thus favoring the clearance of these products. HDLs are emerging also as a relevant player during parasitic infections, and a specific component of HDL, namely, apoL-1, confers innate immunity against trypanosome by favoring lysosomal swelling which kills the parasite. During virus infections, proteins associated with the modulation of cholesterol bioavailability in the lipid rafts such as ABCA1 and SR-BI have been shown to favor virus entry into the cells. Pharmacological studies support the benefit of recombinant HDL or apoA-I mimetics during bacterial infection, while apoL-1-nanobody complexes were tested for trypanosome infection. Finally, SR-BI antagonism represents a novel and forefront approach interfering with hepatitis C virus entry which is currently tested in clinical studies. From the coming years, we have to expect new and compelling observations further linking HDL to innate immunity and infections.
Showing items related by title, author, creator and subject.
Catapano, A.; Pirillo, A.; Bonacina, F.; Norata, Giuseppe (2014)During infections or acute conditions high-density lipoproteins cholesterol (HDL-C) levels decrease very rapidly and HDL particles undergo profound changes in their composition and function. These changes are associated ...
Pirillo, A.; Bonacina, F.; Norata, Giuseppe; Catapano, A. (2018)Purpose of Review: Atherosclerosis is an inflammatory disorder of the arterial wall, in which several players contribute to the onset and progression of the disease. Besides the well-established role of lipids, specifically ...
Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart studyAlonso, A.; Yin, X.; Roetker, N.; Magnani, J.; Kronmal, R.; Ellinor, P.; Chen, L.; Lubitz, S.; McClelland, R.; McManus, D.; Soliman, E.; Huxley, Rachel; Nazarian, S.; Szklo, M.; Heckbert, S.; Benjamin, E. (2014)© 2014 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. Background-Dyslipidemia is a major contributor to the development of atherosclerosis and coronary disease. Its role in ...